 Connection
Matthew Kelly to Microbial Sensitivity Tests
This is a "connection" page, showing publications Matthew Kelly has written about Microbial Sensitivity Tests.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.861 |
|
|
|
-
Hurst JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, Patel SM, Gilchrist J, Maciejewski J, Luinstra K, Smieja M, Steenhoff AP, Cunningham CK, Pelton SI, Kelly MS. Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019). PLoS One. 2024; 19(5):e0302400.
Score: 0.813
-
Bradley JS, Makieieva N, T?ndel C, Roilides E, Kelly MS, Patel M, Vaddady P, Maniar A, Zhang Y, Paschke A, Chen LF. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase?1b, Open-Label, Single-Dose Clinical Trial. J Clin Pharmacol. 2023 12; 63(12):1387-1397.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|